Standout Papers

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook 2020 2026 2022 2024745
  1. Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook (2020)
    Josep Garcia, Herbert I. Hurwitz et al. Cancer Treatment Reviews

Immediate Impact

1 by Nobel laureates 54 standout
Sub-graph 1 of 23

Citing Papers

H3K18 Lactylation Potentiates Immune Escape of Non–Small Cell Lung Cancer
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
2 intermediate papers

Works of Regula Deurloo being referenced

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
2020 Standout

Author Peers

Author Last Decade Papers Cites
Regula Deurloo 454 202 216 307 12 902
Harald Hugenschmidt 415 187 267 385 13 822
Jianhua Wang 493 135 264 374 12 947
Luc Morat 502 287 211 367 24 1.0k
Shengnan Yu 481 236 147 359 24 876
Ricardo Costa 397 209 294 489 17 1.0k
Sujatha Jagadeeswaran 357 166 196 457 16 959
Simon A. Williams 337 178 189 520 24 958
Reena Philip 552 278 273 386 23 1.0k
Charles Pottier 355 209 295 525 15 1.0k
Luigi Manenti 454 111 169 328 18 859

All Works

Loading papers...

Rankless by CCL
2026